Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors

[1]  J. Troppmair,et al.  TD-GC-MS Analysis of Volatile Metabolites of Human Lung Cancer and Normal Cells In vitro , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[2]  Hossam Haick,et al.  Sniffing the unique "odor print" of non-small-cell lung cancer with gold nanoparticles. , 2009, Small.

[3]  H. Haick,et al.  Diagnosing lung cancer in exhaled breath using gold nanoparticles. , 2009, Nature nanotechnology.

[4]  M. Fiegl,et al.  Noninvasive detection of lung cancer by analysis of exhaled breath , 2009, BMC Cancer.

[5]  Vincent M Rotello,et al.  Detection and differentiation of normal, cancerous, and metastatic cells using nanoparticle-polymer sensor arrays , 2009, Proceedings of the National Academy of Sciences.

[6]  I. Horváth,et al.  Exhaled biomarkers in lung cancer , 2009, European Respiratory Journal.

[7]  Magdalena Ligor,et al.  Determination of volatile organic compounds in exhaled breath of patients with lung cancer using solid phase microextraction and gas chromatography mass spectrometry , 2009, Clinical chemistry and laboratory medicine.

[8]  A. Dzien,et al.  The analysis of healthy volunteers' exhaled breath by the use of solid-phase microextraction and GC-MS , 2008, Journal of breath research.

[9]  A. Karellas,et al.  Breast cancer imaging: a perspective for the next decade. , 2008, Medical physics.

[10]  H. Haick,et al.  Detecting simulated patterns of lung cancer biomarkers by random network of single-walled carbon nanotubes coated with nonpolymeric organic materials. , 2008, Nano letters.

[11]  P. Mazzone,et al.  Analysis of volatile organic compounds in the exhaled breath for the diagnosis of lung cancer. , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[12]  A. Jemal,et al.  Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.

[13]  S. Márquez-Calderón,et al.  Cancer surveillance based on imaging techniques in carriers of BRCA1/2 gene mutations: a systematic review. , 2008, The British journal of radiology.

[14]  N. Bârsan,et al.  Electronic nose: current status and future trends. , 2008, Chemical reviews.

[15]  Hossam Haick,et al.  Chemical sensors based on molecularly modified metallic nanoparticles , 2007 .

[16]  Leiliane Coelho A Amorim,et al.  Breath air analysis and its use as a biomarker in biological monitoring of occupational and environmental exposure to chemical agents. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[17]  P. Španěl,et al.  The challenge of breath analysis for clinical diagnosis and therapeutic monitoring. , 2007, The Analyst.

[18]  P. Jain,et al.  Au nanoparticles target cancer , 2007 .

[19]  David Smith,et al.  Breath analysis: the approach towards clinical applications. , 2007, Mini reviews in medicinal chemistry.

[20]  D. Niederseer,et al.  Gender and age specific differences in exhaled isoprene levels , 2006, Respiratory Physiology & Neurobiology.

[21]  J. Pawliszyn,et al.  SPME in environmental analysis , 2006, Analytical and bioanalytical chemistry.

[22]  L. Bianchi,et al.  Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study , 2005, Respiratory research.

[23]  L. Freitag,et al.  METABOLITES IN HUMAN BREATH: ION MOBILITY SPECTROMETERS AS DIAGNOSTIC TOOLS FOR LUNG DISEASES , 2005 .

[24]  Mandana Vahabi,et al.  BREAST CANCER SCREENING METHODS: A REVIEW OF THE EVIDENCE , 2003, Health care for women international.

[25]  M. Phillips,et al.  Volatile Markers of Breast Cancer in the Breath , 2003, The breast journal.

[26]  T. Holland,et al.  Analysis of formaldehyde in the headspace of urine from bladder and prostate cancer patients using selected ion flow tube mass spectrometry. , 1999, Rapid communications in mass spectrometry : RCM.

[27]  M. Phillips,et al.  Variation in volatile organic compounds in the breath of normal humans. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[28]  R. Cataneo,et al.  Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study , 1999, The Lancet.

[29]  C. Kneepkens,et al.  The potential of the hydrocarbon breath test as a measure of lipid peroxidation. , 1994, Free radical biology & medicine.

[30]  P. Sobotka,et al.  Pentane and isoprene in expired air from humans: gas-chromatographic analysis of single breath. , 1994, Clinical chemistry.

[31]  E. Shaw.  Principles and Practice of Radiation Oncology , 1992 .

[32]  C. Perez,et al.  Principles and Practice of Radiation Oncology , 1987 .

[33]  David M Cutler,et al.  Are we finally winning the war on cancer? , 2008, The journal of economic perspectives : a journal of the American Economic Association.

[34]  K. Unterkofler,et al.  Breath isoprene – aspects of normal physiology related to age, gender and cholesterol profile as determined in a proton transfer reaction mass spectrometry study , 2008, Clinical chemistry and laboratory medicine.

[35]  N. Baltayiannis,et al.  Early breast cancer: A review , 2008 .

[36]  A. Gazdar,et al.  Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

[37]  Christopher J. Kiely,et al.  Synthesis and reactions of functionalised gold nanoparticles , 1995 .

[38]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[39]  S. Singer,et al.  The fluid mosaic model of the structure of cell membranes. , 1972, Science.